- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Glial Fibrillary Acidic Protein antibody detects GFAP, a type III intermediate filament protein encoded by the GFAP gene. GFAP is a defining marker of astrocytes in the central nervous system and plays a critical role in maintaining cytoskeletal structure and mechanical strength in glial cells. Because of its restricted expression and diagnostic importance, GFAP is widely used in neuroscience, neuropathology, and brain injury research.
GFAP filaments contribute to the structural framework of astrocytes, providing resilience against mechanical stress while anchoring other cytoskeletal components. They are also involved in signaling pathways that regulate cell shape, migration, and interactions with neurons and endothelial cells. GFAP is upregulated in response to injury or disease, where astrocytes undergo hypertrophy and proliferation in a process known as reactive gliosis. This makes GFAP detection an essential tool for monitoring neuroinflammation and neurodegeneration.
The Glial Fibrillary Acidic Protein antibody clone GFAP/2076 provides specific and reproducible detection of this astrocytic protein. Clone GFAP/2076 has been used in peer-reviewed studies investigating central nervous system injury, astrocyte biology, and glial tumor diagnostics. Recombinant production ensures lot-to-lot consistency, enabling reproducible results across long-term projects.
Research using clone GFAP/2076 has clarified how GFAP expression distinguishes astrocytomas and glioblastomas from other central nervous system tumors. In neuropathology, GFAP detection is a cornerstone of diagnostic classification, providing insight into tumor origin and grade. In basic science, GFAP serves as a marker for studying glial cell development, interactions with neurons, and astrocytic contributions to synaptic homeostasis.
GFAP is not only a diagnostic marker but also an indicator of neurological disease processes. Elevated GFAP levels are found in cerebrospinal fluid and serum after traumatic brain injury, making it a potential biomarker for clinical monitoring. Studies employing GFAP antibodies have explored its use in Alzheimer disease, multiple sclerosis, and other neurodegenerative conditions where astrocyte reactivity plays a role.
NSJ Bioreagents supplies this Glial Fibrillary Acidic Protein antibody to support neuroscience, pathology, and regenerative biology. Alternate names include GFAP antibody, astrocytic filament protein antibody, type III intermediate filament protein antibody, and glial marker antibody.
Optimal dilution of the Glial Fibrillary Acidic Protein antibody should be determined by the researcher.
A portion of amino acids 101-200 were used as the immunogen for the Glial Fibrillary Acidic Protein antibody.
Store the Glial Fibrillary Acidic Protein antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.